1. ALK Inhibitors or Chemotherapy for Third Line in ALK-positive NSCLC? Real-world Data. (28th January 2022) Authors: Moskovitz, Mor; Dudnik, Elizabeth; Shamai, Sivan; Rotenberg, Yakir; Popovich-Hadari, Noa; Wollner, Mira; Zer, Alona; Gottfried, Maya; Mishaeli, Moshe; Rosenberg, Shoshana Keren; Onn, Amir; Merimsky, Ofer; Urban, Damien; Peled, Nir; Maimon, Natalie; Bar, Jair Journal: Oncologist Issue: Volume 27:Number 1(2022) Page Start: e76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Alternative nivolumab duration and scheduling in advanced nonsmall cell lung cancer: A real‐world evidence. Issue 5 (16th September 2020) Authors: Dudnik, Elizabeth; Moskovitz, Mor; Agbarya, Abed; Gottfried, Teodor; Shochat, Tzippy; Urban, Damien; Zer, Alona; Rotem, Ofer; Moore, Assaf; Yust, Shlomit; Peled, Nir; Wollner, Mira; Bar, Jair Journal: International journal of cancer Issue: Volume 148:Issue 5(2021) Page Start: 1183 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Association between multitarget tyrosine kinase inhibitors and changes in CT appearance of submucosal fat in the gastrointestinal tract. Issue 5 (October 2021) Authors: Tamir, Shlomit; Gavrielli, Shlomo; Abitbol, Chen; Tau, Noam; Grubstein, Ahuva; Neiman, Victoria; Yosef, Lilach; Atar, Eli; Zer, Alona Journal: Tumori Issue: Volume 107:Issue 5(2021) Page Start: 432 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial. Issue 7 (July 2019) Authors: West, Howard; McCleod, Michael; Hussein, Maen; Morabito, Alessandro; Rittmeyer, Achim; Conter, Henry J; Kopp, Hans-Georg; Daniel, Davey; McCune, Steven; Mekhail, Tarek; Zer, Alona; Reinmuth, Niels; Sadiq, Ahad; Sandler, Alan; Lin, Wei; Ochi Lohmann, Tania; Archer, Venice; Wang, Lijia; Kowanetz, M... Journal: Lancet oncology Issue: Volume 20:Issue 7(2019) Page Start: 924 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. BIOM-01. TYROSINE KINASE INHIBITORS AS A TREATMENT OF SYMPTOMATIC CNS METASTASES IN ONCOGENE-DRIVEN NSCLC. (9th November 2020) Authors: Benouaich-Amiel, Alexandra; Gal, Omer; Dudnik, Elizabeth; Rotem, Ofer; Finket, Inbar; Peretz, Idit; Zer, Alona; Mandel, Jacob; Siegal, Tali; Bar, Jair; Yust-Katz, Shlomit Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Can Ipilimumab restore immune response in advanced NSCLC after progression on anti‐PD‐1/PD‐L1 agents?. Issue 8 (16th June 2020) Authors: Sternschuss, Michal; Peled, Nir; Allen, Aaron M.; Dudnik, Elizabeth; Rotem, Ofer; Kurman, Noga; Gal, Omer; Reches, Hiba; Zer, Alona Journal: Thoracic cancer Issue: Volume 11:Issue 8(2020) Page Start: 2331 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Characteristics of lung cancer in idiopathic pulmonary fibrosis with single lung transplant versus non-transplanted patients: a retrospective observational study. Issue 1 (21st June 2020) Authors: Gershman, Evgeni; Zer, Alona; Pertzov, Barak; Shtraichman, Osnat; Shitenberg, Dorit; Heching, Moshe; Rosengarten, Dror; Kramer, Mordechai Journal: BMJ open respiratory research Issue: Volume 7:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Characteristics of lung cancer in idiopathic pulmonary fibrosis with single lung transplant versus non-transplanted patients: a retrospective observational study. Issue 1 (21st June 2020) Authors: Gershman, Evgeni; Zer, Alona; Pertzov, Barak; Shtraichman, Osnat; Shitenberg, Dorit; Heching, Moshe; Rosengarten, Dror; Kramer, Mordechai Journal: BMJ open respiratory research Issue: Volume 7:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Characteristics of lung cancer in idiopathic pulmonary fibrosis with single lung transplant versus non-transplanted patients: a retrospective observational study. Issue 1 (21st June 2020) Authors: Gershman, Evgeni; Zer, Alona; Pertzov, Barak; Shtraichman, Osnat; Shitenberg, Dorit; Heching, Moshe; Rosengarten, Dror; Kramer, Mordechai Journal: BMJ open respiratory research Issue: Volume 7:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Characteristics of lung cancer in idiopathic pulmonary fibrosis with single lung transplant versus non-transplanted patients: a retrospective observational study. Issue 1 (21st June 2020) Authors: Gershman, Evgeni; Zer, Alona; Pertzov, Barak; Shtraichman, Osnat; Shitenberg, Dorit; Heching, Moshe; Rosengarten, Dror; Kramer, Mordechai Journal: BMJ open respiratory research Issue: Volume 7:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗